Aspirin, salicylates, and nonsteroidal anti-inflammatory drugs: new class labeling and medical practice.
Roth
S H
SH
Arthritis Center, Ltd., Phoenix, Arizona 85012.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000145:classification*; D001241:Aspirin / Q000009:adverse effects / Q000145:classification*; D004348:Drug Labeling; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D012459:Salicylates / Q000009:adverse effects / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates; D001241:Aspirin